AMY CLAUNCH: Open Payments
NPI 1861943029 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,134 in 65 payments from 19 companies in 2025. Trend: 2023 $1,796 · 2024 $1,797 · 2025 $1,134
Food & beverage: $1,134
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $210 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $190 |
| PFIZER INC. | 12 | $159 |
| Vanda Pharmaceuticals Inc. | 4 | $97 |
| Novo Nordisk Inc | 4 | $74 |
| GlaxoSmithKline, LLC. | 4 | $70 |
| Sumitomo Pharma America, Inc. | 3 | $52 |
| Neurocrine BioSciences, Inc. | 2 | $49 |
| Verona Pharma, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $30 |
Products named: Kerendia, NURTEC ODT, FANAPT, QULIPTA, VRAYLAR, Wegovy, TRELEGY ELLIPTA, GEMTESA.
Industry payments across KY — which companies pay providers there.
